Hours: Mn-Fr: 9 AM–5 PM. Sa-Sn: Closed

Address: 91 Hartwell Ave, Lexington, MA 02421 | Phone: (781) 676-2100

Author : Rudolf Baumgartner

Dr. Baumgartner joined Inotek as Chief Medical Officer in June 2007, overseeing all aspects of clinical development and medical affairs. He brings a deep background as a Pulmonary and Critical Care physician with significant experience in pharmaceutical and biotechnology development. Before Inotek, he was the VP of Clinical Research and Therapeutic Area Head for Respiratory and Immunology at Sepracor Inc., where he successfully led the filing and approval of multiple NDAs, including two that the FDA approved in the first review cycle. His previous roles include Director of Clinical Research at Merck and post-doctoral research at the NIH, after completing his medical training at the University of Michigan and Johns Hopkins University.

The Potential Risks of Water-Based Eye Drops – Understanding Chemicals, Side Effects, and Alternatives

Introduction to the Growing Concerns Regarding Water-based Eye Drops With the increasing awareness of potential health hazards associated with everyday products, a recent report by the Washington Post has shed light on the risks linked to water-based eye drops. While eye drops are commonly used to alleviate dry eyes, redness, and irritation, there are concerns […]

New Vuity Eye Drops – Revolutionizing Vision Care

Introduction of New Eye Drops for Improved Vision The world of vision care has been revolutionized with the introduction of a new prescription eye drop called Vuity. These innovative eye drops have quickly gained recognition for their ability to enhance vision and provide relief from various eye conditions. Improved Vision: Vuity eye drops offer a […]

Scroll to top